Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease

Area of Science:

• Microbiology
• Molecular Biology
• Biochemistry

Background:

• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) provide adaptive immunity in prokaryotes against nucleic acid invaders.
• CRISPR-mediated nucleic acid cleavage mechanisms are diverse, with limited understanding of their specific molecular actions.
• The Type III-A CRISPR system in Staphylococcus epidermidis utilizes the Csm1 protein, featuring nuclease-like domains.

Purpose of the Study:

• To investigate the in vitro nuclease activity of the Staphylococcus epidermidis Csm1 protein.
• To elucidate the mechanism and substrate specificity of Csm1-mediated cleavage.
• To understand the role of Csm1 in CRISPR immunity and RNA processing.

Main Methods:

• Recombinant expression and purification of S. epidermidis Csm1 protein.
• In vitro biochemical assays to assess DNA and RNA cleavage activity.
• Site-directed mutagenesis to identify key catalytic residues, focusing on the GGDD motif.

Main Results:

• Recombinant S. epidermidis Csm1 exhibits single-stranded DNA and RNA exonuclease activity in the 3'-5' direction.
• Both DNA and RNA cleavage activities are dependent on divalent metal ions.
• The catalytic activity resides within the GGDD motif of the Csm1 cyclase-like domain.

Conclusions:

• S. epidermidis Csm1 possesses dual DNA/RNA exonuclease activity crucial for CRISPR-mediated defense.
• The identified catalytic domain and metal ion dependence provide insights into the mechanism of Type III-A CRISPR systems.
• Csm1 likely functions within an effector complex to degrade foreign nucleic acids and aid in CRISPR RNA maturation.